Colorectal Cancer
Conditions
Brief summary
Colorectal cancer (CRC) is the second most commonly occurring cancer worldwide. Thirty-five percent of CRC patients are diagnosed at stage II/III, and their outcome differs even if they are in the same stage. Previous study found that the microenvironmental collagen is associated with tumor progression and metastasis. Whether tumor microenvironmental collagen signature is associated with colorectal cancer prognosis still remains unknown. We hypothesize that the tumor microenvironmental collagen signature of colorectal cancer is associated with prognosis.
Detailed description
Colorectal cancer (CRC) is the second most commonly occurring cancer worldwide. Thirty-five percent of CRC patients are diagnosed at stage II/III, and their outcome differs even if they are in the same stage. In the seed and soil theory proposed by Stephen Paget, tumor cells play the role of the seed, and the tumor microenvironment (TME) is the soil. TNM classification provides useful but uncomplete prognosis information in colorectal cancer. It lacks the assessment of the soil signature of tumor microenvironment. Previous study found that the microenvironmental collagen is associated with tumor progression and metastasis. Whether tumor microenvironmental collagen signature is associated with colorectal cancer prognosis still remains unknown. This study is a retrospective observational study performed in two centers. The main purpose of this study was to investigate whether the tumor microenvironment collagen signature (CSTME) can discriminate the 5-year DFS of stage II/III CRC patients, the secondary purpose is to compare the AUC (area under the receiver operating characteristic curve) of TNM stage+CSTME in predicting 5-year DFS with that of TNM stage alone. This study would introduce the tumor microenvironmental collagen signature into current colorectal cancer classification system, which would provide reference for clinical practice.
Interventions
Tumor microenvironment collagen signature
Sponsors
Study design
Eligibility
Inclusion criteria
* Pathologically diagnosed with colorectal cancer * TNM stages II and III (according to the 8th edition of AJCC Cancer Staging Manual) * Received radical tumor resection surgery
Exclusion criteria
* ASA grade 4 * Preoperative radiotherapy and/or chemotherapy * Hereditary colorectal cancer * Pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 5-year DFS | 5 years followup after surgery | 5-year disease free survival |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 5-year OS | 5 years followup after surgery | 5-year overall survival |
Countries
China